New report provides further evidence that our Nano product has been tested for efficacy against SARS-CoV-2virus
EDGGroup can confirm that the long-term Nano wipe-on glass coating surface protection product used has now been tested for efficacy against SARS-CoV-2 virus.
This update via a new report adds to existing tests against TGEV Coronavirus certification for the product used by EDGGroup Ltd. This serves as further evidence of efficacy against enveloped viruses. It is also the intention to continue testing on SARS-CoV-2 in 2021 and beyond to give full confidence of product and process application by the EDGGroup team.
As we know the vaccines are out, yet likely that pandemic restrictions will be part of our lives in 2021 and the proven antiviral activity against SARS-CoV-2 are key to keeping staff, stakeholder and the population safe. However, any new norm will need to embrace a level of learning from 2020 and this pandemic, of which surface protection is a vital role in the fight against the transmission of transient microbes, especially in high touch areas that are hard to clean between “touches”.
Our Nano product also protects against the transmission of other viral and bacterial pathogens that come into contact with surfaces, thus reducing the spread of coughs and colds.
